Video Experimental Relacionado
Updated: Jan 22, 2026
01:08
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Published on: October 3, 2025
261
Un nuevo mediador entre las proteínas activadoras y el aparato de transcripción de la ARN polimerasa II
R J Kelleher1, P M Flanagan, R D Kornberg
1Department of Cell Biology, Fairchild Center, Stanford University School of Medicine, California 94305.
Cell
|June 29, 1990
Resumen
Las proteínas activadoras de genes pueden interferir con la función de las otras en las células eucariotas. Un nuevo factor de levadura invierte esta interferencia, lo que sugiere que media en la activación transcripcional.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Regulación genética Reglamento genético.
- La transcripción de los eucariotas.
Sus antecedentes:
- Las proteínas activadoras de genes regulan la expresión génica al unirse al ADN y reclutar maquinaria de transcripción.
- Puede ocurrir interferencia entre diferentes activadores de genes, lo que afecta los procesos celulares.
- Comprender estas interacciones es crucial para descifrar los mecanismos de regulación génica.
Objetivo del estudio:
- Para investigar el fenómeno de la interferencia del activador en las células eucariotas.
- Identificar los factores involucrados en la regulación de las interacciones de las proteínas activadoras de genes.
- Para dilucidar el mecanismo por el cual se modula la interferencia del activador.
Principales métodos:
- Construcción y prueba de una proteína activadora del gen híbrido levadura-herpes.
- Pruebas de transcripción in vitro para estudiar la interferencia del activador.
- Purificación bioquímica de un componente de la levadura que invierte la interferencia.
Principales resultados:
- Se demostró que una proteína activadora de genes híbrida inhibe la activación transcripcional por un elemento específico del ADN en la levadura.
- Esta interferencia del activador fue reproducible en experimentos in vitro.
- Un componente de levadura parcialmente purificado, distinto de la ARN polimerasa II y otros factores de transcripción, revirtió la interferencia.
Conclusiones:
- La interferencia del activador es un proceso biológico demostrable en la regulación génica de los eucariotas.
- Un nuevo factor de levadura juega un papel en la modulación de la interferencia del activador.
- Este nuevo factor probablemente media en el proceso de activación transcripcional, destacando un nuevo mecanismo regulador.
Videos de Conceptos Relacionados
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
02:30siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
02:30Small interfering RNAs (siRNA)
4.3K
No description available
4.3K
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
01:16Hepatic Drug Excretion: Influencing Factors
539
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539